184 related articles for article (PubMed ID: 11108141)
1. The salted artery and angiotensin II signaling: a deadly duo in arterial disease.
Wang M; Lakatta EG
J Hypertens; 2009 Jan; 27(1):19-21. PubMed ID: 19050444
[No Abstract] [Full Text] [Related]
2. MiR-449a-5p mediates mitochondrial dysfunction and phenotypic transition by targeting Myc in pulmonary arterial smooth muscle cells.
Zhang C; Ma C; Zhang L; Zhang L; Zhang F; Ma M; Zheng X; Mao M; Shen T; Zhu D
J Mol Med (Berl); 2019 Mar; 97(3):409-422. PubMed ID: 30715622
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension.
Johnson AW; Kinzenbaw DA; Modrick ML; Faraci FM
Hypertension; 2013 Feb; 61(2):437-42. PubMed ID: 23266544
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.
Valencia JC; Pacheco-Rodriguez G; Carmona AK; Xavier J; Bruneval P; Riemenschneider WK; Ikeda Y; Yu ZX; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 2006 Jul; 35(1):40-7. PubMed ID: 16474096
[TBL] [Abstract][Full Text] [Related]
5. Functional cross-talk between the cyclic AMP and Jak/STAT signaling pathways in vascular smooth muscle cells.
Meloche S; Pelletier S; Servant MJ
Mol Cell Biochem; 2000 Sep; 212(1-2):99-109. PubMed ID: 11108141
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
Dostal DE; Hunt RA; Kule CE; Bhat GJ; Karoor V; McWhinney CD; Baker KM
J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in angiotensin II signaling.
Touyz RM; Berry C
Braz J Med Biol Res; 2002 Sep; 35(9):1001-15. PubMed ID: 12219172
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification.
Osako MK; Nakagami H; Shimamura M; Koriyama H; Nakagami F; Shimizu H; Miyake T; Yoshizumi M; Rakugi H; Morishita R
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1287-96. PubMed ID: 23580147
[TBL] [Abstract][Full Text] [Related]
10. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
Leduc I; Haddad P; Giasson E; Meloche S
Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882
[TBL] [Abstract][Full Text] [Related]
11. p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle.
Meloche S; Landry J; Huot J; Houle F; Marceau F; Giasson E
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H741-51. PubMed ID: 10924074
[TBL] [Abstract][Full Text] [Related]
12. Functional significance of oligomerization of G-protein-coupled receptors.
Salahpour A; Angers S; Bouvier M
Trends Endocrinol Metab; 2000 Jul; 11(5):163-8. PubMed ID: 10856916
[TBL] [Abstract][Full Text] [Related]
13. The Janus kinase family of protein tyrosine kinases and their role in signaling.
Yeh TC; Pellegrini S
Cell Mol Life Sci; 1999 Sep; 55(12):1523-34. PubMed ID: 10526570
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
